Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation

BACKGROUND: β-blockers (BBs) are considered primary therapy in stable heart failure (HF) with reduced ejection fraction (HFrEF) without atrial fibrillation (AF); evidence-based benefits of BB on outcome have been documented. However, BBs have not been shown to improve mortality or reduce hospital ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Min-Soo, Yoo, Byung-Su, Son, Jung-Woo, Yu, Min Heui, Kang, Dae Ryong, Lee, Hae-Young, Jeon, Eun-Seok, Kim, Jae-Joong, Chae, Shung Chull, Baek, Sang Hong, Kang, Seok-Min, Choi, Dong-Ju, Kim, Kye Hun, Cho, Myeong-Chan, Kim, Seong Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445305/
https://www.ncbi.nlm.nih.gov/pubmed/32830467
http://dx.doi.org/10.3346/jkms.2020.35.e278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445305/
https://www.ncbi.nlm.nih.gov/pubmed/32830467
http://dx.doi.org/10.3346/jkms.2020.35.e278

Ejemplares similares